Weight-loss jabs might help with certain heart conditions, but their benefit is being overstated.
Articles on Semaglutide
Displaying 41 - 52 of 52 articles
The messaging around Ozempic being a miracle cure is not only a lie, it has kicked up a new level of fatphobia.
Ongoing shortages of the drug have been reported in the UK, Australi and Ireland.
Overreliance on BMI as a measure of weight and health has deepened inequities and led to inaccuracies and overgeneralizations.
As the use of Ozempic, a drug for diabetes, slams into the mainstream as a weight-loss method, will the drug’s use impact our concept of fatness? And how does fatness intersect with race and class?
Some pharmacies are selling ‘generic’ semaglutide online, despite the drug still being under patent protection.
Obesity is said to cost the NHS an estimated £6 billion a year.
The much-discussed weight-loss jab may be good for treating Britain’s biggest killer: dementia. Trials are underway.
Ozempic uses semaglutide to mimic the role of a hormone naturally produced by the body to create feelings of fullness. Certain foods can do the same thing.
Overweight or obese patients who meet certain criteria will soon be able to access the much talked about weight-loss jab.
You’ve probably heard of the drug semaglutide or Ozempic, the diabetes medication being used for weight loss. So what are the risks and benefits? And who should have access to it?
Semaglutide works by controlling appetite.
Top contributors
-
Associate Professor of Metabolic Medicine, University of Surrey
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Professor of Community Health and Wellbeing, The University of Queensland
-
Accredited Practising Dietitian and Lecturer, Southern Cross University
-
Associate Professor of Physiology and Medical Education, Anglia Ruskin University
-
General Practitioner, PhD Candidate, Bond University
-
Head of the Translational Nanomedicine & Biotherapeutics Group and Senior Research Fellow, Adelaide University
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
ARC Future Fellow, School of Biomedical Sciences, The University of Queensland
-
Laureate Professor in Nutrition and Dietetics, University of Newcastle
-
Assistant Professor, Critical Disability Studies, Carleton University
-
Senior Lecturer, Nutrition and Food Science, Australian Catholic University
-
Clinical Epidemiologist, Washington University in St. Louis
-
Adjunct Senior Research Fellow, Global and Women's Health, School of Public Health & Preventive Medicine, Monash University
-
Research Lead/Advanced Clinical Practitioner/Senior Research Fellow, University of Bradford